Pore, A. A., Bithi, S. S., Zeinali, M., Navaid, H. B., Nagrath, S., Layeequr Rahman, R., & Vanapalli, S. A. (2022). Phenotyping of rare circulating cells in the blood of non-metastatic breast cancer patients using microfluidic Labyrinth technology. Biomicrofluidics, 16(6), 064107. https://doi.org/10.1063/5.0129602

 

Khan, S. Y., Melkus, M. W., & Layeequr Rahman, R. (2023). ASO Author Reflections: Cryoablation Cost-Benefit Analysis: Managing Breast Cancer Through Cost-Effective Therapy. Annals of surgical oncology, 30(2), 1038–1039. https://doi.org/10.1245/s10434-022-12669-9

 

Khan, S. Y., Snitman, A., Habrawi, Z., Crawford, S., Melkus, M. W., & Layeequr Rahman, R. (2023). ASO Visual Abstract: The Role of Cryoablation in Breast Cancer Beyond the Oncologic Control: COST and Breast-Q Patient Reported Outcomes. Annals of surgical oncology, 30(2), 1040–1041. https://doi.org/10.1245/s10434-022-12610-0

 

Khan, S. Y., Snitman, A., Habrawi, Z., Crawford, S., Melkus, M. W., & Layeequr Rahman, R. (2023). The Role of Cryoablation in Breast Cancer Beyond the Oncologic Control: COST and Breast-Q Patient-Reported Outcomes. Annals of surgical oncology, 30(2), 1029–1037. https://doi.org/10.1245/s10434-022-12570-5

 

Jensen, B., Khan, H., & Layeequr Rahman, R. (2022). Sociodemographic Determinants in Breast Cancer Screening among Uninsured Women of West Texas. Medicina (Kaunas, Lithuania), 58(8), 1010. https://doi.org/10.3390/medicina58081010

 

Khan SY, Melkus MW, Layeequr Rahman R. ASO Author Reflections: How can we Measure an Abscopal Effect Seen with Cryoablation? Ann Surg Oncol. 2022 Jan 7. doi: 10.1245/s10434-021-11220-6. Epub ahead of print. PMID: 34994898.

 

Khan SY, Melkus MW, Rasha F, Castro, M, Chu, V, Brandi, L, Khan, H, Gill, HS, Pruitt, K, Layeerqur Rahman, R. Tumor Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer – A Pilot Study. Ann Surg Oncol. 2021. 2022 Jan 29. doi: 10.1245/s10434-021-11157-w. Epub ahead of print. PMID: 35094188.

​

Khan SY, Melkus MW, Rasha F, Castro M, Chu V, Brandi L, Khan H, Gill HS, Pruitt K, Layeequr Rahman R. ASO Visual Abstract: Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer-A Pilot Study. Ann Surg Oncol. 2022 Jan 25. doi: 10.1245/s10434-021-11240-2. Epub ahead of print. PMID: 35076772.

​

Khan SY, Chu V, Melkus MW, Layeequr Rahman R. Cryoablation is a safe alternative to surgery for low-risk breast cancer. J Cancer Biol 2021; 2(1):22-24.

 

Habrawi Z, Melkus MW, Khan S, Henderson J, Brandi L, Chu V, Layeequr Rahman R. Cryoablation: A promising non-operative therapy for low-risk breast cancer. Am J Surg. 2021 Jan;221(1):127-133. doi: 10.1016/j.amjsurg.2020.07.028. Epub 2020 Aug 1. PMID: 32788081.

 

Molehin D, Rasha F, Rahman RL, Pruitt K. Regulation of aromatase in cancer. Mol Cell Biochem. 2021 Jun;476(6):2449-2464. doi: 10.1007/s11010-021-04099-0. Epub 2021 Feb 18. PMID: 33599895.

 

Jahan N, Jones C, Rahman RL. Endocrine prevention of breast cancer. Mol Cell Endocrinol. 2021 Jun 15;530:111284. doi: 10.1016/j.mce.2021.111284. Epub 2021 Apr 18. PMID: 33882282.

 

Ugras SK, Layeequr Rahman R. Hormone replacement therapy after breast cancer: Yes, No or maybe? Mol Cell Endocrinol. 2021 Apr 5;525:111180. doi: 10.1016/j.mce.2021.111180. Epub 2021 Jan 26. PMID: 33508379.

 

De Miranda FS, Guimarães JPT, Menikdiwela KR, Mabry B, Dhakal R, Rahman RL, Moussa H, Moustaid-Moussa N. Breast cancer and the renin-angiotensin system (RAS): Therapeutic approaches and related metabolic diseases. Mol Cell Endocrinol. 2021 May 15;528:111245. doi:

​

Jahan N, Jones C, Rahman RL. Androgen receptor expression in breast cancer: Implications on prognosis and treatment, a brief review. Mol Cell Endocrinol. 2021 Jul 1;531:111324. doi: 10.1016/j.mce.2021.111324. Epub 2021 May 14. PMID: 34000352.